Status:
RECRUITING
PET/MRI to Stage Prostate Cancer Patients
Lead Sponsor:
IRCCS San Raffaele
Conditions:
Prostate Cancer
Eligibility:
MALE
18+ years
Phase:
PHASE2
Brief Summary
The main goal of this phase II clinical trial is to define a novel approach of staging prostate cancer (PCa) patients by using a fully integrated positron emission tomography/ magnetic resonance imagi...
Detailed Description
This is a prospective monocentric open study (Phase II study). The study will include 50 consecutive PCa patients who will be recruited in the first 36 months of the study. All clinical and pathologic...
Eligibility Criteria
Inclusion
- Age ≥ 18 years-old
- Biopsy proven high-grade PCa referred to prostatectomy and pelvic/retroperitoneal lymphadenectomy.
- Willing to provide a signed informed consent
Exclusion
- Age \< 18 years-old
- Inability to complete the needed imaging examinations (i.e. severe claustrophobia)
- Any additional medical condition that may significantly interfere with study compliance
- All the contraindications for MRI study (i.e. pacemaker)
- Evidence of metastatic disease on conventional imaging contraindicating the surgical procedure
Key Trial Info
Start Date :
September 9 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2025
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06484361
Start Date
September 9 2020
End Date
September 30 2025
Last Update
July 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS Ospedale San Raffaele
Milan, Italy, 20132